Skip to main content

Reactions Weekly

Ausgabe 1/2009

Inhalt (101 Artikel)

Case report

Adenosine/verapamil

Case report

Alendronic acid

Case report

Antihyperglycaemics

Case report

Antineoplastics

Case report

Antiretrovirals

Case report

Arsenic trioxide

Case report

Atomoxetine/SLI 381

Case report

Bevacizumab

Case report

Cabergoline

Case report

Cefdinir

Case report

Cyproheptadine

Case report

Cytarabine

Case report

Deferiprone

Case report

Donepezil

Case report

Doxycycline

Case report

Efalizumab

Case report

Efalizumab withdrawal

Case report

Enoxaparin sodium

Case report

Epinephrine

Case report

Epoetin α

Case report

Ethambutol

Case report

Ethambutol

Case report

Flecainide

Case report

Fluindione

Case report

Fluindione

Case report

Gemcitabine

Case report

Heparin

Case report

Hydroxycarbamide

Case report

Imatinib

Case report

Imatinib

Case report

Imatinib

Case report

Imatinib

Case report

Imatinib/interferon

Case report

Immunosuppressants

Case report

Infliximab

Case report

Infliximab

Case report

Insulin

Case report

Interferon α-2b

Case report

Iodoform

Case report

Isoniazid overdose

Case report

Labetalol

Case report

Lapatinib

Case report

Levodopa withdrawal

Case report

Lidocaine/prilocaine

Case report

Linezolid

Case report

Lithium

Case report

Methotrexate

Case report

Methotrexate

Case report

Methylphenidate

Case report

Minocycline

Case report

Mitoxantrone

Case report

Morphine

Case report

Olanzapine

Case report

Olanzapine

Case report

Ondansetron

Case report

Paclitaxel

Case report

Paclitaxel

Case report

Pamidronic acid

Case report

Risperidone

Case report

Rituximab

Case report

Rituximab

Case report

Sertraline

Case report

Sildenafil

Case report

Somatropin

Case report

Sulprostone

Case report

Sunitinib

Case report

Sunitinib

Case report

Tacrolimus

Case report

Thalidomide

Case report

Triamcinolone

Case report

Triamcinolone

Case report

Trypan blue

Case report

Voriconazole